Ajani J - Search Results

1

Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.

Yen CJ, Izzo JG, Lee DF, Guha S, Wei Y, Wu TT, Chen CT, Kuo HP, Hsu JM, Sun HL, Chou CK, Buttar NS, Wang KK, Huang P, Ajani J, Hung MC. Yen CJ, et al. Among authors: ajani j. Cancer Res. 2008 Apr 15;68(8):2632-40. doi: 10.1158/0008-5472.CAN-07-5460. Cancer Res. 2008. PMID: 18413730 Free PMC article.

2

In vitro activity of bleomycin, tallysomycin S10b, and liblomycin against fresh human tumor cells.

Tueni EA, Newman RA, Baker FL, Ajani JA, Fan D, Spitzer G. Tueni EA, et al. Among authors: ajani ja. Cancer Res. 1989 Mar 1;49(5):1099-102. Cancer Res. 1989. PMID: 2465080

3

Reduction of difluoromethylornithine-induced thrombocytopenia in rats with ornithine while maintaining antitumor activity.

Grossie VB Jr, Ota DM, Ajani JA, Chang TH, Patenia D, Nishioka K. Grossie VB Jr, et al. Among authors: ajani ja. Cancer Res. 1989 Aug 1;49(15):4159-62. Cancer Res. 1989. PMID: 2501023

4

Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach.

Kim YH, Ajani JA, Ota DM, Lynch P, Roth JA. Kim YH, et al. Among authors: ajani ja. Cancer. 1995 Jan 15;75(2):451-6. doi: 10.1002/1097-0142(19950115)75:2<451::aid-cncr2820750207>3.0.co;2-u. Cancer. 1995. PMID: 7812915

5

Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review.

Medgyesy CD, Wolff RA, Putnam JB Jr, Ajani JA. Medgyesy CD, et al. Among authors: ajani ja. Cancer. 2000 Jan 15;88(2):262-7. Cancer. 2000. PMID: 10640955 Review.

6

A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.

Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA. Ajani JA, et al. Cancer. 2001 Jul 15;92(2):279-86. doi: 10.1002/1097-0142(20010715)92:2<279::aid-cncr1320>3.0.co;2-2. Cancer. 2001. PMID: 11466680 Clinical Trial.

7

Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer.

Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, Yao J, Ajani J, Xie K. Wang L, et al. Among authors: ajani j. Clin Cancer Res. 2003 Dec 15;9(17):6371-80. Clin Cancer Res. 2003. PMID: 14695137

8

Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.

Yao JC, Wang L, Wei D, Gong W, Hassan M, Wu TT, Mansfield P, Ajani J, Xie K. Yao JC, et al. Among authors: ajani j. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4109-17. doi: 10.1158/1078-0432.CCR-03-0628. Clin Cancer Res. 2004. PMID: 15217947

9

Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.

Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Dabaja BS, et al. Among authors: ajani j. Cancer. 2004 Aug 1;101(3):518-26. doi: 10.1002/cncr.20404. Cancer. 2004. PMID: 15274064 Free article.

10

Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.

Ajani JA, Mansfield PF, Crane CH, Wu TT, Lunagomez S, Lynch PM, Janjan N, Feig B, Faust J, Yao JC, Nivers R, Morris J, Pisters PW. Ajani JA, et al. J Clin Oncol. 2005 Feb 20;23(6):1237-44. doi: 10.1200/JCO.2005.01.305. J Clin Oncol. 2005. PMID: 15718321 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

913 results

Search Page